卵巢癌风险预测:从临床流行病学角度看
Nicolas Wentzensen1, Kari Ring2, Britt K Erickson3
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, MD, United States.
American journal of epidemiology
|August 21, 2024
概括
改善卵巢癌风险预测对于早期检测和预防至关重要. 目前的模型的准确性有限,因此需要进一步研究更有效的风险评估策略,以对这种异质性疾病进行评估.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 遗传学 遗传学 是一个
背景情况:
- 卵巢癌是一种罕见的,异质性疾病,往往是晚诊的,导致结果不佳.
- 基于人口的查未能降低死亡率;然而,预防性手术对高风险群体有效.
- 针对性干预和早期检测策略需要准确的风险预测模型.
研究的目的:
- 为预测卵巢癌风险提出一个终身方法.
- 评估现有的风险预测模型的有效性,并确定需要改进的领域.
主要方法:
- 对已发表的卵巢癌风险预测模型的审查.
- 使用曲线下的面积 (AUC) 值进行区分能力的分析.
- 考虑风险因素和遗传易感性标志物.
主要成果:
- 现有的卵巢癌风险模型显示出有限的区分能力,AUC从0.58到0.65.
- 在一般人群中预测的终身风险 (0.6%2.5%) 低于预防性手术的4%门.
- 目前的模型需要改进,以准确识别个人进行预防性干预.
结论:
- 增强的卵巢癌风险预测模型对于有效的早期检测和预防策略至关重要.
- 需要进一步的研究来开发改进的模型,并为较低风险的个人探索新的预防方法.
- 一个终身的方法可以改进对卵巢癌的风险评估.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Relative Risk
128
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
128
Odds Ratio
114
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
114
Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103


